scss - isct joint symposium 2019...scss - isct joint symposium 2019 13 - 15 november, sgh campus,...

1
KEYNOTES Bruce LEVINE ISCT President-Elect, Univ. of Pennsylvania, USA Fiona WOOD Royal Perth Hospital, Australia SPEAKERS Antonio BERTOLETTI Duke-NUS, Singapore Bryan CHOI ATEMS, Korea Christine CHEUNG Nanyang Technilogical University, Singapore Justin COOPER-WHITE University of Queensland, AUS John CONNOLLY IMCB, Singapore Anthony DAVIES Dark House Consulting, USA Mohammad FIRDAUS University of Malaya, Malaysia Akitsu HOTTA CiRA, Kyoto University, Japan Ohad KARNIELI ATVIO, Israel Shin KAWAMATA Foundation for Biomedical Research & Innovation, Japan Mickey KOH St George’s Hospital, UK Tony LEE Medipost, Korea Mayasari LIM RoosterBio, USA Xiangliang LIN Esco Aster, Singapore Wendy LIPWORTH University of Sydney, Australia Tamra LYSAGHT National University Singapore Charlotte MORGAN Regeneus, Australia May-Ning NAING National University Singapore Michael LOTZE University Pittsburgh, USA Max MOMONKIN Baylor College, USA Lee Lee ONG Health Sciences Authority, Singapore Thang T PHAN Cell Research Corp, Singapore Jai SIVALINGAM Biopreocessing Technology Insitute, Singapore Cameron STEWART University of Sydney, Australia Shigeki SUGII Institute of Bioengineering & Nanotechnology, Singapore Satoshi TAKAHASHI University of Tokyo, Japan Lip Kun TAN National University Health System, Singapore Drew TITMARSH Scaled Biolabs, USA Monica TJIN Duke-NUS Medical School, Singapore Shu WANG NUS, Singapore Wen Bo WANG Fate Therapeutics, USA Francis WONG SingHealth, Singapore Lynn YAP Duke-NUS Medical School, Singapore SCSS - ISCT Joint Symposium 2019 13 - 15 November, SGH Campus, Singapore “FRONTIERS IN CELL THERAPY” Organizers Shigeki SUGII IBN, Singapore Simon COOL IMCB, Singapore John CONNOLLY IMCB, Singapore Ray DUNN IMB, Singapore Melissa LIN BTI, Singapore Tamra LYSAGHT NUS, Singapore Steve OH BTI, Singapore M. PASTERNAK ISCT, Canada K. TRYGGVASON Duke-NUS, Singapore Gerald UDOLPH SCSS, Singapore stemcell.org.sg/scss-isct-2019 Stem Cell Therapy • Immuno & Gene Therapy • Ethics & Regulation • Advanced Technologies • Manufacturing & Quality Control • Business of Cell & Gene Therapy Registration Early bird & abstract submission 25 September 2019 Regular registration 30 October 2019 Trainee Early Bird SGD 460 Trainee Regular SGD 560 Academic Early Bird SGD 650 Academic Regular SGD 750 (incl. ISCT 2020 & SCSS 2019/20 membership fees) Contact [email protected]

Upload: others

Post on 06-Feb-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

  • KEYNOTESBruce LEVINEISCT President-Elect, Univ. of Pennsylvania, USA

    Fiona WOODRoyal Perth Hospital, Australia

    SPEAKERSAntonio BERTOLETTIDuke-NUS, Singapore

    Bryan CHOIATEMS, Korea

    Christine CHEUNGNanyang TechnilogicalUniversity, Singapore

    Justin COOPER-WHITEUniversity of Queensland, AUS

    John CONNOLLYIMCB, Singapore

    Anthony DAVIESDark House Consulting, USA

    Mohammad FIRDAUSUniversity of Malaya, Malaysia

    Akitsu HOTTACiRA, Kyoto University, Japan

    Ohad KARNIELIATVIO, Israel

    Shin KAWAMATAFoundation for Biomedical Research & Innovation, Japan

    Mickey KOHSt George’s Hospital, UK

    Tony LEEMedipost, Korea

    Mayasari LIMRoosterBio, USA

    Xiangliang LINEsco Aster, Singapore

    Wendy LIPWORTHUniversity of Sydney, Australia

    Tamra LYSAGHTNational University Singapore

    Charlotte MORGANRegeneus, Australia

    May-Ning NAINGNational University Singapore

    Michael LOTZEUniversity Pittsburgh, USA

    Max MOMONKINBaylor College, USA

    Lee Lee ONGHealth Sciences Authority, Singapore

    Thang T PHAN Cell Research Corp, Singapore

    Jai SIVALINGAMBiopreocessing Technology Insitute, Singapore

    Cameron STEWARTUniversity of Sydney, Australia

    Shigeki SUGIIInstitute of Bioengineering & Nanotechnology, Singapore

    Satoshi TAKAHASHIUniversity of Tokyo, Japan

    Lip Kun TANNational University HealthSystem, Singapore

    Drew TITMARSHScaled Biolabs, USA

    Monica TJINDuke-NUS Medical School, Singapore

    Shu WANGNUS, Singapore

    Wen Bo WANGFate Therapeutics, USA

    Francis WONGSingHealth, Singapore

    Lynn YAPDuke-NUS Medical School, Singapore

    SCSS - ISCT Joint Symposium 2019

    13 - 15 November, SGH Campus, Singapore

    “FRONTIERS IN CELL THERAPY”

    OrganizersShigeki SUGIIIBN, Singapore

    Simon COOLIMCB, Singapore

    John CONNOLLYIMCB, Singapore

    Ray DUNNIMB, Singapore

    Melissa LINBTI, Singapore

    Tamra LYSAGHTNUS, Singapore

    Steve OHBTI, Singapore

    M. PASTERNAKISCT, Canada

    K. TRYGGVASONDuke-NUS, Singapore

    Gerald UDOLPHSCSS, Singapore

    stemcell.org.sg/scss-isct-2019

    Stem Cell Therapy • Immuno & Gene Therapy • Ethics & Regulation • Advanced Technologies • Manufacturing & Quality Control • Business of Cell & Gene Therapy

    Registration

    Early bird & abstract submission

    25 September 2019

    Regular registration

    30 October 2019

    Trainee Early Bird SGD 460

    Trainee Regular SGD 560

    Academic Early Bird SGD 650

    Academic Regular SGD 750

    (incl. ISCT 2020 & SCSS 2019/20 membership fees)

    [email protected]